Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Burdock Root

Middle-Aged Mice Fed Antibiotic Lived Longer
US researchers found that feeding middle-aged mice the antibiotic rapamycin, an anti-fungal agent originally discovered in the soil of Easter
generic viagra online
The Australian Community Continues To Value Nurses: Nurses Voted The Most 'ethical And Honest' Profession For The 15th Year Running
The Australian Nursing Federation (ANF) says the annual Roy Morgan professions survey, which shows nurses are regarded as the most "ethical and honest" of all professions, confirms the Australian public continues to appreciate the benefits nurses bring to Australia"s health.
News of the day
Questions Over The Gates Foundation's Allocation Of Funds-To Whom Do They Answer?
A paper in this week"s Lancet raises questions about the transparency, accountability and governance of the Gates Foundation (GF). This Health Policy paper is written by Dr David McCoy, Centre for International Development, UCL (University College London), UK, and colleagues. An Editorial and Comment accompany the piece.
Endocrinology

UK Court Of Appeal Rules In Smith & Nephew's Favour

Smith & Nephew"s Advanced Wound Management division (NYSE:SNN) announced that the UK Court of Appeal has ruled as invalid all claims asserted against Smith and Nephew of the patent EP 0 626 720 that is licensed to Kinetic Concepts, Inc. (NYSE: KCI). As a result, the preliminary injunction against Smith & Nephew"s RENASYS(TM)-F NPWT system has been lifted. The Patents Court had ruled on 1 May, 2009 that 7 out of 10 claims asserted were invalid but that the remaining 3 had been infringed by Smith & Nephews RENASYS-F dressing. This decision was appealed and subsequently won by Smith & Nephew with today"s Court ruling. "This favourable ruling for Smith & Nephew clears a major legal hurdle in the UK allowing us to offer our customers the breadth of NPWT products with proven clinical efficacy," said Robin Carlstein, Senior Vice President of Advanced Wound Devices at Smith & Nephew. "Clearly, we are pleased with the UK Court of Appeal"s findings in this matter and look forward to servicing our customers with our RENASYS(TM)-F NPWT products in a very important market for the company." Smith & Nephew


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009